Skip to content

Evidence Hub

Blog
Jan 21, 2021

Real-world data in the era of COVID-19: Expert perspectives on the changing data landscape

The COVID-19 pandemic has brought forth a new era of collaboration between health care ...
Start Reading
Blog
Jan 14, 2021

Applying regulatory experience in the technology space: Q&A with Lowell Schiller, Chief Legal and Regulatory Officer at Aetion

Lowell Schiller, J.D., recently joined Aetion as Chief Legal and Regulatory Officer, ...
Start Reading
Blog
Jan 7, 2021

Research spotlight: Using RWE to evaluate complications of COVID-19

While COVID-19 is primarily a respiratory disease, its impact has also been associated ...
Start Reading
Blog
Dec 17, 2020

Interim results of the RCT-DUPLICATE Project: Dr. Jessica Franklin on learnings thus far

The RCT-DUPLICATE project began in 2018 with the goal of informing the use of real-world ...
Start Reading
Blog
Dec 10, 2020

RWE Guidance Watch: NICE updates methods for health technology evaluations

With real-world evidence (RWE) growing in influence across health care, regulatory and ...
Start Reading
Blog
Dec 7, 2020

Data Synthesis Platform Available for the PHUSE Community

By Kayley Phillpott Posted On: December 7th, 2020
Start Reading
Blog
Nov 26, 2020

CNIL Recommends Against US Service Providers for Processing Health Data – What Does that Mean?

Organizations processing the personal data of EU citizens, and data from France in ...
Start Reading
Blog
Nov 24, 2020

RWE Guidance Watch: MHRA draft guidance on RCTs generating RWE to support regulatory decisions

With real-world evidence (RWE) growing in influence across health care, regulatory and ...
Start Reading
Blog
Nov 12, 2020

How can real-world data support opioid addiction research? Q&A with Dr. Jacob “Gus” Crothers of Groups Recover Together

The opioid epidemic is one of the greatest public health challenges this century, and its ...
Start Reading
Blog
Nov 5, 2020

ICPE research spotlight: Part III: Standard-setting research to advance the use of RWE

This year at ICPE All Access, Aetion’s scientific research is represented across 15 ...
Start Reading
Blog
Oct 29, 2020

Generating real-world evidence from chargemaster data: Q&A with Myla Maloney of Premier, Inc.

Most real-world data (RWD) sets are based on claims data, which provides useful ...
Start Reading
Blog
Oct 28, 2020

Can synthetic data help organizations respond to 'Schrems II'?

By Mike Hintze, Khaled El Emam Posted On: October 28th, 2020 Can synthetic data help ...
Start Reading
Blog
Oct 21, 2020

How can small- to mid-sized biopharma generate insights from RWD? Q&A with Michael Sanky of Optum Life Sciences

Optum, a new Aetion data collaborator, offers a robust range of real-world data (RWD) ...
Start Reading
Blog
Oct 15, 2020

Unlocking insights in RWD for market access and commercial teams: Q&A with Ki Park of Symphony Health

The integrated solutions of Symphony Health, a new Aetion data partner, extract data from ...
Start Reading
Blog
Oct 1, 2020

ICPE research spotlight: Part II: Exploring new methods for RWE research

This year at ICPE All Access, Aetion’s scientific research is represented across 15 ...
Start Reading
Blog
Sep 24, 2020

Ask the Accelerators: Dr. William Morice of Mayo Clinic Laboratories on RWE and COVID-19 diagnostics

Ask the Accelerators is a series highlighting the perspectives and work of organizations ...
Start Reading
Blog
Sep 21, 2020

PETs and Sharing Clinical Trial Data

Janssen’s Head of Clinical Data Standards & Transparency, Stephen Bamford, recently ...
Start Reading
Blog
Sep 16, 2020

ICPE research spotlight: Part I: Expanding real-world applications of RWE

This year at ICPE All Access, Aetion’s scientific research is represented across 15 ...
Start Reading
Blog
Sep 3, 2020

Ask the Accelerators: Dr. Nirosha Lederer on COVID-19’s implications for the future of RWE, and what we’ve learned so far

Ask the Accelerators is a series highlighting the perspectives and work of organizations ...
Start Reading
Blog
Aug 31, 2020

Three recommendations for generating regulatory-grade RWE: Considerations for the FDA on PDUFA VII

With the passage of the 21st Century Cures Act and the sixth Prescription Drug User Fee ...
Start Reading
Blog
Aug 20, 2020

Structuring epidemiology teams to maximize impact of RWE: Q&A with Dr. Nicolle Gatto

Nicolle Gatto, Ph.D., is the Senior Vice President of Scientific Research at Aetion, ...
Start Reading
Blog
Aug 19, 2020

Death to Privacy Shield

PETs to the Rescue in the Wake of the Privacy Shield Verdict Due to contemporary ...
Start Reading
Blog
Aug 13, 2020

How can AI and RWD work together to improve understanding of chronic diseases? Q&A with Kathryn Starzyk, Head of RWE at OM1

OM1, a new Aetion data partner, curates deep clinical real-world data (RWD) from ...
Start Reading
Blog
Aug 7, 2020

PETs to Manage Emerging Privacy Risks

As the pace of technological innovation continues to grow, new risks to consumer and ...
Start Reading